Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Urol. 2012 Aug;188(2):413-4. doi: 10.1016/j.juro.2012.04.070. Epub 2012 Jun 14.

Re: Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma.

PMID:
22784718
[PubMed]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk